L_老虎社区_美港股上老虎

StansenSG
2022-01-20

Novavax Covid-19 Vaccine Cleared in Australia

Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had gran

Novavax Covid-19 Vaccine Cleared in Australia

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":630390897,"tweetId":"630390897","gmtCreate":1642687953408,"gmtModify":1642687955968,"author":{"id":3578711428062414,"authorId":3578711428062414,"authorIdStr":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>L</p></body></html>","htmlText":"<html><head></head><body><p>L</p></body></html>","text":"L","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/630390897","repostId":1105143250,"repostType":4,"repost":{"id":"1105143250","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642686991,"share":"https://www.laohu8.com/m/news/1105143250?lang=&edition=full","pubTime":"2022-01-20 21:56","market":"us","language":"en","title":"Novavax Covid-19 Vaccine Cleared in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1105143250","media":"Tiger Newspress","summary":"Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had gran","content":"<html><head></head><body><p>Novavax shares rose over 2% premarket as Australia&#39;s Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.</p><p><img src=\"https://static.tigerbbs.com/8bd516836472463166488720fec8e99f\" tg-width=\"852\" tg-height=\"650\" referrerpolicy=\"no-referrer\"/></p><p>Australia&#39;s Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> for those aged 18 years and above, the company announced Thursday.</p><p>The country will receive the vaccine shipments under the brand name Nuvaxovid.</p><p>Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world&#39;s largest vaccine manufacturer is set to supply the initial doses to Australia.</p><p>&#34;The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax&#39;s increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,&#34; said Novavax (NVAX) CEO Stanley C. Erck.</p><p>In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Covid-19 Vaccine Cleared in Australia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Covid-19 Vaccine Cleared in Australia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-20 21:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Novavax shares rose over 2% premarket as Australia&#39;s Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.</p><p><img src=\"https://static.tigerbbs.com/8bd516836472463166488720fec8e99f\" tg-width=\"852\" tg-height=\"650\" referrerpolicy=\"no-referrer\"/></p><p>Australia&#39;s Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> for those aged 18 years and above, the company announced Thursday.</p><p>The country will receive the vaccine shipments under the brand name Nuvaxovid.</p><p>Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world&#39;s largest vaccine manufacturer is set to supply the initial doses to Australia.</p><p>&#34;The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax&#39;s increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,&#34; said Novavax (NVAX) CEO Stanley C. Erck.</p><p>In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105143250","content_text":"Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.Australia's Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by Novavax  for those aged 18 years and above, the company announced Thursday.The country will receive the vaccine shipments under the brand name Nuvaxovid.Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world's largest vaccine manufacturer is set to supply the initial doses to Australia.\"The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax's increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,\" said Novavax (NVAX) CEO Stanley C. Erck.In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1014,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Novavax Covid-19 Vaccine Cleared in Australia

评论（1）

热议股票